Detalhe da pesquisa
1.
A Prognostic Survival Model Incorporating Patient-Reported Outcomes for Transplant-Ineligible Patients With Multiple Myeloma.
Oncologist
; 2024 Apr 18.
Artigo
Inglês
| MEDLINE | ID: mdl-38636951
2.
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study.
Haematologica
; 108(12): 3384-3391, 2023 Dec 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37439357
3.
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis.
Eur J Haematol
; 111(5): 815-823, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37574220
4.
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).
Am J Hematol
; 98(8): 1277-1285, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37334773
5.
Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia.
Biol Blood Marrow Transplant
; 24(12): 2466-2470, 2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30036572
6.
The Association Between the Urine Protein-to-Albumin Gap and the Diagnosis of Multiple Myeloma: A Population-Based Retrospective Cohort Study.
Am J Kidney Dis
; 81(6): 732-734, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36586559
7.
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: A population-based cohort study.
Am J Hematol
; 98(8): E197-E199, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37190964
8.
Outcomes of multiple myeloma patients with del 17p undergoing autologous stem cell transplantation.
Am J Hematol
; 96(1): E35-E38, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33068019
9.
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL).
Leuk Lymphoma
; : 1-8, 2024 Apr 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38625039
10.
Treatment Pattern, Healthcare Resource Utilization and Symptom Burden Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study.
Clin Lymphoma Myeloma Leuk
; 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38431522
11.
Predictors and Impact of Timing of Disease Progression Following Primary Therapy in Multiple Myeloma.
Clin Lymphoma Myeloma Leuk
; 24(3): e104-e111.e1, 2024 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38135634
12.
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy.
Front Immunol
; 14: 1166038, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37205115
13.
An atlas of the bone marrow bone proteome in patients with dysproteinemias.
Res Sq
; 2023 Jan 23.
Artigo
Inglês
| MEDLINE | ID: mdl-36747663
14.
An atlas of the bone marrow bone proteome in patients with dysproteinemias.
Blood Cancer J
; 13(1): 63, 2023 04 28.
Artigo
Inglês
| MEDLINE | ID: mdl-37105956
15.
Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis.
Blood Cancer J
; 13(1): 111, 2023 07 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37474492
16.
Outcomes after biochemical or clinical progression in patients with multiple myeloma.
Blood Adv
; 7(6): 909-917, 2023 03 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35413102
17.
The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma.
Curr Hematol Malig Rep
; 17(6): 306-318, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36417082
18.
Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method.
Blood Adv
; 6(12): 3746-3750, 2022 06 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35316833
19.
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.
Blood Cancer J
; 12(4): 67, 2022 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35440099
20.
Second- and third-line treatment strategies in multiple myeloma: a referral-center experience.
Blood Cancer J
; 12(12): 164, 2022 12 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36473843